Novartis logo

Novartis

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Antwerp terminal

Health & Healthcare | Novartis

Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers

The Energize program is a collaboration between 10 global pharmaceutical companies, including Novartis, to engage hundreds of suppliers in bold climate action and decarbonization of the pharmaceutical value chain.

Flexible Media Releases

Africa Has a New Health Challenge, and We Need a Plan to Fight It

More than 750 Million Anti Malaria Treatments for Adults and Children Provided Without Profit

Experts Discuss Better Treatments Against Parasitic Diseases

Novartis and Red Cross Partner to Tackle Chronic Diseases in Refugee Populations

First Novartis Access Treatments Delivered to Kenya

Novartis Foundation Commemorates World Leprosy Day with its Continued Efforts to go the Last Mile Toward Elimination

Novartis Releases 2015 Corporate Responsibility Performance Report

The Novartis Foundation and the London School of Hygiene & Tropical Medicine Join Forces to Put Hypertension Care and Management on the Global Health Agenda

Novartis Foundation and Partners Launch New Hypertension Program in Ghana

Kenya First Country to Launch ‘Novartis Access’, Expanding Affordable Treatment Options Against Chronic Diseases

Eradicating Malaria Through Innovation: Where Next After 2015?

About the Novartis Malaria Initiative

Novartis Launches ‘Novartis Access’, a Portfolio of Affordable Medicines to Treat Chronic Diseases in Lower-income Countries

Novartis Foundation Presents Healthcare Models and Disease Elimination Programs at ECTMIH

Novartis Continues Commitment to go the Last Mile in Effort to Eliminate Leprosy

Campaigns

Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US
Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on...

Novartis US Foundation
Initiatives summarizing efforts from the Novartis US Foundation.

Novartis COVID-19 Trials
Novartis clinical trial efforts in COVID-19 R&D.

Novartis US Foundation COVID-19 Response
In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one...

Novartis – science based innovation for better patient outcomes
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novartis Foundation Leprosy Elimination Initiative
The Novartis Foundation is convening experts from the global health and anti-leprosy community to discuss the current state of leprosy treatment and...

Novartis Access: Medicines to treat chronic diseases in lower-income countries
Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to...

The Novartis Malaria Initiative
For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...

Videos

Contact Novartis
email
corporate.responsibility@novartis.com
open_in_new
Learn more about corporate responsibility at Novartis
open_in_new
Novartis Foundation